Bayer Innovation Procurement Expands Use of Scientist.com’s AI-Powered Platform for Global R&D Procurement Orchestration
16.6.2025 13:55:00 CEST | Business Wire | Press release
Bayer AG Innovation Procurement and Scientist.com have signed a multi-year extension that elevates Scientist.com to Bayer’s preferred global channel for sourcing external R&D services.
A Journey from Tactical to Strategic Partnership
The alliance began in 2015, when Bayer adopted Scientist.com’s digital marketplace to streamline and control long-tail spend in preclinical research. Over the years, this relationship has deepened and expanded, reflecting Bayer’s broader shift toward externalizing more of its R&D activities as part of its innovation strategies. What started as a tactical procurement tool has now become Bayer’s preferred global channel for sourcing a wide spectrum of external R&D services.
Comprehensive R&D Outsourcing Capabilities
With the expansion, Scientist.com’s platform will support Bayer across the entire R&D value chain, including:
- Strategic preclinical supplier management, with guided buying, rate-card compliance, and performance tracking.
- Clinical development services, offering unified workflows for study execution, biomarker analysis, and central laboratory capabilities.
- Real-world evidence, data analytics, health economics, and market access solutions, providing rapid access to top-tier data partners.
- Crop science research, including specialized agriscience testing and regulatory studies.
Driving Digital Transformation and Innovation
By designating Scientist.com as its preferred sourcing channel, Bayer Innovation Procurement has created a single digital entry point for its scientists – enabling access to both strategic and niche providers, automating governance, supporting sustainability goals, and generating actionable insights from aggregated procurement data. This transformation is part of Bayer Innovation Procurement’s strategy to empower Bayer researchers and increase the flexibility and productivity of R&D activities in line with the company wide operating model Dynamic Shared Ownership. The full expansion of Crop Science Research and Clinical Development Services are expected to steadily roll out over the next 6-12 months to enable for the onboarding of Bayer’s full provider list.
Leadership Perspectives
“Scientist.com has proven its value right from the beginning, and this extension makes it the one place our scientists go for most of their external work,” said Dr. Kirstin Meyer, SVP and Head of Pre-clinical Development Research, Bayer AG. “With a single entry point we can reach strategic and niche providers alike, ensure governance, drive our sustainability goals and – critically – generate insights from the aggregated data to guide future decisions.”
“Bayer is showing how a digital procurement orchestration platform can serve as an enterprise solution that streamlines an entire research organization's sourcing processes," said Dr. Dan Kagan, President & COO, Scientist.com. “Together we’re adding new AI tools, deeper data integrations and end-to-end compliance so Bayer teams across Pharma and Crop Science can innovate faster and smarter.”
Scientist.com’s AI-enabled platform combines supplier discovery, competitive bidding, contracting, compliance checks and spend analytics in one secure environment, giving Bayer researchers a seamless path to the expertise they need while unlocking portfolio-level insights from the underlying data.
A Model for the Future of R&D
The evolution of Bayer’s partnership with Scientist.com exemplifies how leading life science organizations are moving beyond tactical procurement toward strategic, digitally enabled R&D outsourcing. This approach not only enhances operational efficiency but also positions Bayer to better leverage global expertise, accelerate innovation, and respond to changing scientific and market demands.
About Scientist.com
Scientist.com is the life-science industry’s premier AI-powered marketplace and procurement-orchestration platform. Founded in 2007 and headquartered in Solana Beach, California, the company simplifies every stage of drug discovery and development by unifying supplier search, competitive bidding, contracting, compliance and analytics in a single, secure workspace. More than 20 of the world’s top 30 pharma companies, 100+ biotech organizations and the US National Institutes of Health rely on Scientist.com to access a vetted network of 6,000+ specialized providers, shorten cycle times and reduce costs while meeting the highest ethical and regulatory standards. Discover how Scientist.com accelerates science at Scientist.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250616174530/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer Multiplica3.4.2026 13:30:00 CEST | Pressemeddelelse
Andersen Consulting indgår en samarbejdsaftale med Multiplica, et digitalt konsulentfirma, der hjælper organisationer med at designe, bygge og skalere effektfulde digitale oplevelser. Multiplica, der er stiftet i Spanien og desuden har aktiviteter i Latinamerika og USA, fokuserer på brugerundersøgelser og behovsafdækning, research af kundeoplevelser, digital strategi, datamodellering og -analyse, rapportautomatisering og datavisualisering, konverteringsoptimering, produktdesign og design af brugeroplevelser. Virksomheden hjælper organisationer med at fremskynde den digitale transformation ved at opbygge digitale kompetencer, teams og aktiver, der fremmer ekspertise på tværs af digitale produkter, rådgivning og talentudvikling. Multiplica gør det muligt for kunder at prognosticere nye tendenser inden for digitale oplevelser og transformere deres forretninger gennem styrkede digitale kanaler og kundeengagement. "Samarbejdet med Andersen Consulting udgør en spændende mulighed for at udvid
Enry’s Island Unveils “Enry’s Island Adventures”: Venture Capital Becomes a Videogame and Launches the “Strap” Movement on Kickstarter3.4.2026 09:47:00 CEST | Press release
Gaming, finance, and lifestyle merge to democratize the startup ecosystem: Enry’s Island opens 2026 applications for game development studios seeking more than just capital. Enry’s Island SpA (WBAG: EIOS), the world’s first publicly traded Venture Builder, today announced the upcoming Kickstarter launch of Enry’s Island Adventures (EIA), developed by its New York-based portfolio company, Enry’s Island Adventures LLC. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402548535/en/ The game is designed to make venture capital accessible to new generations, transforming startup creation into an engaging and social gaming experience. After three years of R&D, EIA introduces a "bleisure" model (business + leisure): players learn to launch and manage startups through gameplay that includes real business KPIs, a customizable and evolving personal island, synchronous and asynchronous multiplayer modes, social events, and community-d
SES Announces Results of the Annual General Meeting2.4.2026 16:49:00 CEST | Press release
SES (the “Company”) held the Annual General Meeting (“AGM”) of Shareholders today in Betzdorf, Luxembourg. Following the recommendations made by the Board of Directors of SES, the shareholders have voted in favor of all resolutions, including the Company’s 2025 annual accounts and the proposed annual dividend of EUR 0.50 per A-share (EUR 0.20 per B-share). The total dividend amount comprises the interim dividend of EUR 0.25 per A-share (EUR 0.10 per B-share), which has already been paid to shareholders on October 16, 2025. The final dividend of EUR 0.25 per A-share (EUR 0.10 per B-share) will be paid to shareholders on April 16, 2026. “I would like to sincerely thank our shareholders for their active engagement, visionary support and continued confidence in SES’ strategy,” said Adel Al-Saleh, CEO of SES. “The outcomes of today’s AGM underscore our shared commitment to a bold multi-orbit approach, with Medium Earth Orbit as the strategic backbone of a dynamically evolving global interco
Andersen Consulting styrker sine kompetencer med tilføjelsen af Lukkap2.4.2026 16:31:00 CEST | Pressemeddelelse
Andersen Consulting tilføjer samarbejdspartneren Lukkap, et konsulenthus med fokus på oplevelsesdrevne kompetencer, der er tilpasset kundernes skiftende behov inden for transformation af medarbejdere, kunder og det digitale område. Lukkap, der blev stiftet i 2009 og har hovedsæde i Spanien, leverer integrerede løsninger, der hjælper organisationer med at transformere, hvordan de betjener kunder, engagerer medarbejdere og frigør værdi gennem adfærdsindsigt og dataanalyse. Virksomhedens tværfaglige tilgang spænder over nytænkning af kunderejsen, effektive programmer for medarbejderoplevelser, talent- og ledelsesudvikling, prædiktiv analyse samt omfattende outplacement- og transitionsydelser. Lukkap arbejder på tværs af sektorer — herunder sundhedsvæsen, medicinalindustri, forbrugsgoder, detailhandel, finans og bankvæsen — for at opbygge menneskecentrerede strategier, der skaber målbare forretningsresultater. "Ved at kombinere vores erfaringsdrevne metode med Andersen Consultings globale
Forrester: Three Years Into GenAI, Enterprises Are Still Chasing Its True Transformative Value2.4.2026 16:00:00 CEST | Press release
Low AI fluency, uneven adoption, and marginal productivity gains are limiting enterprise-scale impact According to Forrester’s (Nasdaq: FORR) latest report, Accelerate Your AI Voyage, most enterprises are struggling to turn growing AI adoption and investment into measurable business impact. One of the key factors holding businesses back is low artificial intelligence quotient (AIQ) — Forrester’s measure of AI aptitude — with many employees lacking a clear understanding of how to use AI. Other barriers include an overemphasis on productivity-focused use cases, difficulty measuring impact, and siloed adoption within individual functions. While these challenges can leave firms frozen in doubt or indecision, the wait-and-see approach to AI adoption is no longer viable. To unlock AI’s full potential, organizations need to focus on four key areas: Define the business outcomes and success metrics for what they want AI to achieve; identify specific use cases for AI deployment aligned to those
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom